Digital asset investment firm Techemy Capital, in partnership with on-chain asset management company Enzyme Finance, has announced the launch of its Holistic ETH-BTC Portfolio.
Launched in 2013, Techemy Capital provides solutions for professional investors, including fund management, OTC, yield-optimization, and investment intelligence. The company is an authorized Financial Services Provider to wholesale investors under New Zealand law.
Enzyme Finance helps users build and scale their investing strategies with an emphasis on security. The platform provides a safe, easy, and low-cost way to create and operate an investment strategy with built-in accounting tools. Enzyme Finance connects users to a pool of potential investors, making it easier to attract and grow a community of supporters. It also provides access to a large ecosystem of DeFi tokens and protocols.
Powered by Enzyme, Techemy Capital’s Holistic ETH-BTC Portfolio is an actively managed product that provides exposure to bitcoin and Ethereum price action with low fees and enhanced security. Using Techemy Capital’s long and short trading strategies, the portfolio quantifies bullish or bearish conditions to add or subtract from each investor’s starting position, based on an assessment of on-chain activity, token age spent, and technical analysis. The portfolio executes trading decisions using the daily price chart on Brave New Coin’s Bitcoin Liquid Index (BLX) and Ethereum Liquid Index (ELX).
Key features of the Holistic ETH-BTC Portfolio include: non-custodial storage, no human error, transparency, low cost, and flexible subscription & withdrawal. The portfolio’s rotation of assets includes Wrapped Bitcoin ($wBTC), Ethereum ($ETH), USD Coin ($USDC), Inverse ETH ($iETH), and Inverse BTC ($iBTC). These inverse assets, powered by Synthetix, allow Techemy’s traders to profit from a decline in price of the underlying asset. Techemy is able to access deep liquidity across the entire Ethereum network thanks to Enzyme’s integration with Paraswap, a Decentralised Exchange aggregator that optimises order routing and minimises slippage.
Techemy Capital also announced that it will roll out a Managed DeFi Portfolio to offer investors an exposure to the entire DeFi ecosystem.
“Following the exceptional performance of Techemy Capital’s private DeFi Portfolio in 2020, we are excited to open this product through Enzyme to the broader investor community,” said Fran Strajnar, Founder of Techemy Capital and Brave New Coin. “We are looking forward to working with Enzyme and our growing number of exchange partners to deliver the highest-grade digital asset and DeFi investment products.”
Source: Read Full Article